BROOKS LABORATORIES : INCORPORATES WHOLLY OWNED SUBSIDIARY

• Abridge Speciality Limited incorporated as a wholly owned subsidiary on July 2, 2026. • The incorporation aligns with the company's strategic objective to expand its business. • Abridge Speciality Limited is a related party, and Brooks Laboratories Limited will hold 100% share capital. • The subsidiary is in the business of manufacturing and marketing pharmaceuticals and related products. • The subsidiary is newly incorporated and yet to commence business operations, hence turnover/net worth not applicable.

Brooks Laboratories Ltd

Open attachment

← Back to feed